SCHEMBL27433604

SCHEMBL27433604

COC(=O)c1c(OC)c(Cl)cc2c1OCCN2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.36
TAS1R1 Q7RTX1 2/20 0.36
TAS1R2 Q8TE23 1/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 3/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
DRD2 P14416 3/20 0.34
DRD3 P35462 3/20 0.34
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
DHFR P00374 1/20 0.32
KMT2A Q03164 1/20 0.32
HTR1A P08908 1/20 0.32
DRD4 P21917 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
TPMT P51580 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954087 1.00 TAS1R3 (0.36) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL27435302 0.88 ALDH1A1 (0.44) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL27432600 0.87 EGFR (0.34) ALDH1A1KDM4EGAATSHRSMN1; SMN2
SCHEMBL30954101 0.87 EGFR (0.34) ALDH1A1KDM4EGAATSHRSMN1; SMN2
SCHEMBL7269670 0.75 SERPINH1 (0.40) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL28947224 0.74 KDM4E (0.36) ALDH1A1KDM4ETSHRSMN1; SMN2HSD17B10
SCHEMBL30954084 0.73 NR1H2 (0.36) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL27433652 0.73 NR1H2 (0.36) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL27434669 0.72 MAPT (0.39) TAS1R3TAS1R1TAS1R2KDM4EHSD17B10
SCHEMBL24100076 0.72 KDM4E (0.38) ALDH1A1KDM4EGAASMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed